This site is intended for healthcare professionals

BNT 162b2 vaccine interim analysis demonstrates efficacy against COVID- 19.- Pfizer + BioNTech

Read time: 1 mins
Last updated:10th Nov 2020
Published:10th Nov 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest